Enteropathic spondyloarthritis: From diagnosis to treatment

Clinical and Developmental Immunology

Volumn 2013, Issue , 2013, Pages

  Peluso, Rosario ^a   Di Minno, Matteo Nicola Dario ^a   Iervolino, Salvatore ^a   Manguso, Francesco ^b   Tramontano, Giuseppina ^a   Ambrosino, Pasquale ^a   Esposito, Carmela ^a   Scalera, Antonella ^a   Castiglione, Fabiana ^a   Scarpa, Raffaele ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CARDARELLI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ETANERCEPT; HLA B27 ANTIGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLIXIMAB; INTERLEUKIN 12P40; LEFLUNOMIDE; MESALAZINE; METHOTREXATE; PROBIOTIC AGENT; SALAZOSULFAPYRIDINE; STAT3 PROTEIN; ANTIINFLAMMATORY AGENT;

ANKYLOSING SPONDYLITIS; AORTA ARCH SYNDROME; ARTERY THROMBOSIS; BACTERIAL INFECTION; CARDIOVASCULAR RISK; CD4+ T LYMPHOCYTE; CLINICAL CLASSIFICATION; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE PREDISPOSITION; DRUG EFFICACY; ENDOPLASMIC RETICULUM; ENTEROPATHIC ARTHRITIS; ENTEROPATHY; FATTY LIVER; FIBROMYALGIA; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; HISTOPATHOLOGY; HUMAN; IMMUNOCOMPETENT CELL; INCIDENCE; INTESTINE INFECTION; INTESTINE MUCOSA; LYMPHOCYTE DIFFERENTIATION; MEDICAL HISTORY; METABOLIC SYNDROME X; MUTATIONAL ANALYSIS; PATHOGENESIS; PHYSICAL EXAMINATION; PREVALENCE; PRIORITY JOURNAL; PYODERMA GANGRENOSUM; REGULATORY T LYMPHOCYTE; REVIEW; RHEUMATOID ARTHRITIS; SACROILIAC JOINT; SACROILIITIS; SJOEGREN SYNDROME; SPONDYLARTHRITIS; SPONDYLITIS; TH17 CELL; THROMBOPHLEBITIS; VENOUS THROMBOEMBOLISM; DRUG EFFECT; GASTROINTESTINAL TRACT; GENE EXPRESSION; GENETICS; IMMUNOLOGY; INFLAMMATORY BOWEL DISEASE; JOINT; PATHOLOGY; COMPLICATION; DRUG EFFECTS; INFLAMMATORY BOWEL DISEASES;

ANTI-INFLAMMATORY AGENTS; GASTROINTESTINAL TRACT; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; HLA-B27 ANTIGEN; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; JOINTS; SPONDYLARTHRITIS;

EID: 84877303985     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2013/631408     Document Type: Review

References (159)

1. Leirisalo-Repo M., Enteropathic arthritis, Whipple's disease, juvenile spondyloarthropathy, and uveitis. Current Opinion in Rheumatology 1994 6 4 385 390 2-s2.0-0028339025 (Pubitemid 24218406)
2. Orlando A., Renna S., Perricone G., Cottone M., Gastrointestinal lesions associated with spondyloarthropathies. World Journal of Gastroenterology 2009 15 20 2443 2448 2-s2.0-67650106558 10.3748/wjg.15.2443
3. Smith R., Treatment of rheumatoid arthritis by colectomy. Annals of Surgery 1922 76 515 578 10.1097/00000658-192210000-00016
4. Bargen J. A., Jackman R. J., Kerr J. G., Complications and sequel of chronic ulcerative colitis. Annals of Internal Medicine 1929 3 335 352
5. Hench P. S., Whipple G. H., Acute and chronic arthritis. Nelson's Loose Leaf of Surgery 1935 New York, NY, USA Thomas Nelson Sons 104
6. Bywaters E. G., Ansell B. M., Arthritis associated with ulcerative colitis; a clinical and pathological study. Annals of the Rheumatic Diseases 1958 17 2 169 183 2-s2.0-0000078014
7. McBride J. A., King M. J., Baikie A. G., Crean G. P., Sircus W., Ankylosing spondylitis and chronic inflammatory diseases of the intestines. British Medical Journal 1963 2 5355 483 486 2-s2.0-0000445122
8. Steinberg V. L., Storey G., Ankylosing spondylitis and chronic inflammatory lesions of the intestines. British Medical Journal 1957 2 5054 1157 1159 10.1136/bmj.2.5054.1157
9. Stewart J. S., Ansell B. M., Ankylosing spondylitis associated with regional enteritis. Gastroenterology 1963 45 265 268 2-s2.0-75449127966
10. Blumberg B. S., Bunim J. J., Calkins E., Pirani C. L., Zvaifler N. J., Aranomenclature and classification of arthritis and rheumatism (tentative). Arthritis and Rheumatism 1964 7 93 97 2-s2.0-0002808542
11. Wright V., Moll J. H. M., Seronegative Polyarthritis 1976 Amsterdam, The Netherlands North Holland Publishing Company
12. Puite R. H., Tesluk H., Whipple's disease. The American Journal of Medicine 1955 19 3 383 400 2-s2.0-0001575301
13. Kelly J. J. III, Weisiger B. B., The arthritis of Whipple's disease. Arthritis and Rheumatism 1963 6 615 632 2-s2.0-33748587328
14. Friis J., Svejgaard A., Letter: Salmonella arthritis and HL-A27. The Lancet 1974 1 7870 1350 2-s2.0-0016404446
15. Aho K., Ahvonen P., Lassus A., Dumond D. C. P., Yersinia arthritis and related diseases. Infection and Immunology in the Rheumatic Diseases 1976 Oxford Blackwell 341 344
16. Braun J., Sieper J., Building consensus on nomenclature and disease classification for ankylosing spondylitis: results and discussion of a questionnaire prepared for the International Workshop on New Treatment Strategies in Ankylosing Spondylitis, Berlin, Germany, 18-19 January 2002. Annals of the Rheumatic Diseases 2002 61 supplement 3 iii61 iii67 2-s2.0-0036893564 (Pubitemid 35397346)
17. Dougados M., van der Linden S., Juhlin R., Huitfeldt B., Amor B., Calin A., Cats A., Dijkmans B., Olivieri I., Pasero G., Veys E., Zeidler H., The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis and Rheumatism 1991 34 10 1218 1227 2-s2.0-0026003027
18. Cosnes J., Gower-Rousseau C., Seksik P., Cortot A., Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology 2011 140 6 1785 1794 10.1053/j.gastro.2011.01.055
19. Salvarani C., Fries W., Clinical features and epidemiology of spondyloarthritides associated with inflammatory bowel disease. World Journal of Gastroenterology 2009 15 20 2449 2455 2-s2.0-67650169925 10.3748/wjg.15.2449
20. Turkcapar N., Toruner M., Soykan I., Aydintug O. T., Cetinkaya H., Duzgun N., Ozden A., Duman M., The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease. Rheumatology International 2006 26 7 663 668 2-s2.0-33645857394 10.1007/s00296-005-0044-9
21. Scarpa R., del Puente A., D'Arienzo A., Di Girolamo C., Della Valle G., Panarese A., Lubrano E., Oriente P., The arthritis of ulcerative colitis: clinical and genetic aspects. Journal of Rheumatology 1992 19 3 373 377 2-s2.0-0026521610
22. de Vlam K., Mielants H., Cuvelier C., de Keyser F., Veys E. M., de Vos M., Spondyloarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA association. Journal of Rheumatology 2000 27 12 2860 2865 2-s2.0-0033674240
23. Wordsworth P., Arthritis and inflammatory bowel disease. Current Rheumatology Reports 2000 2 2 87 88 2-s2.0-0034172713
24. Rodríguez-Reyna T. S., Martínez-Reyes C., Yamamoto-Furusho J. K., Rheumatic manifestations of inflammatory bowel disease. World Journal of Gastroenterology 2009 15 44 5517 5524 10.3748/wjg.15.5517
25. Palm O., Moum B., Jahnsen J., Gran J. T., The prevalence and incidence of peripheral arthritis in patients with inflammatory bowel disease, a prospective population-based study (the IBSEN study). Rheumatology 2001 40 11 1256 1261 2-s2.0-0035187155
26. Orchard T. R., Wordsworth B. P., Jewell D. P., Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history. Gut 1998 42 3 387 391 2-s2.0-0031957986 (Pubitemid 28197029)
27. Yüksel I., Ataseven H., Başar O., Köklü S., Ertuǧrul I., Ulker A., Daǧli U., Saşmaz N., Peripheral arthritis in the course of inflammatory bowel diseases. Digestive Diseases and Sciences 2011 56 1 183 187 10.1007/s10620-010-1260-z
28. Vavricka S. R., Brun L., Ballabeni P., Pittet V., Prinz Vavricka B. M., Zeitz J., Rogler G., Schoepfer A. M., Frequency and risk factors for extraintestinal manifestations in the swiss inflammatory bowel disease cohort. American Journal of Gastroenterology 2011 106 1 110 119 2-s2.0-78650988140 10.1038/ajg.2010.343
29. Veloso F. T., Carvalho J., Magro F., Immune-related systemic manifestations of inflammatory bowel disease: a prospective study of 792 patients. Journal of Clinical Gastroenterology 1996 23 1 29 34 2-s2.0-0030016118 10.1097/00004836-199607000-00009 (Pubitemid 26244497)
30. Manguso F., Staiano T., Astarita C., Scarpa R., Peluso R., Gargano D., Ayala F., D'Arienzo A., Consecutive occurrence of rhinoconjunctivitis, seronegative spondyloarthritis and pyoderma gangrenosum in a patient with ulcerative colitis. International Journal of Colorectal Disease 2005 20 1 79 80 2-s2.0-11244284865 10.1007/s00384-004-0626-0 (Pubitemid 40057884)
31. Manguso F., Sanges M., Staiano T., Gargiulo S., Nastro P., Gargano D., Somma P., Mansueto G., Peluso R., Scarpa R., D'Armiento F. P., Astarita C., Ayala F., Renda A., Mazzacca G., D'Arienzo A., Cigarette smoking and appendectomy are risk factors for extraintestinal manifestations in ulcerative colitis. American Journal of Gastroenterology 2004 99 2 327 334 2-s2.0-10744227522 10.1111/j.1572-0241.2004.04039.x (Pubitemid 38279877)
32. Cuvelier C., Barbatis C., Mielants H., de Vos M., Roels H., Veys E., Histopathology of intestinal inflammation related to reactive arthritis. Gut 1987 28 4 394 401 2-s2.0-0023157222 (Pubitemid 17056872)
33. de Vos M., Cuvelier C., Mielants H., Veys E., Barbier F., Elewaut A., Ileocolonoscopy in seronegative spondylarthropathy. Gastroenterology 1989 96 2, part 1 339 344 2-s2.0-0024492459 (Pubitemid 19045264)
34. Mielants H., Veys E. M., Joos R., Cuvelier C., de Vos M., Repeat ileocolonoscopy in reactive arthritis. Journal of Rheumatology 1987 14 3 456 458 2-s2.0-0023190178 (Pubitemid 17116922)
35. Mielants H., Veys E. M., Cuvelier C., de Vos M., Botelberghe L., HLA-B27 related arthritis and bowel inflammation-part 2: ileocolonoscopy and bowel histology in patients with HLA-B27 related arthritis. Journal of Rheumatology 1985 12 2 294 298 2-s2.0-0021816009 (Pubitemid 15025372)
36. Scarpa R., Manguso F., D'Arienzo A., D'Armiento F. P., Astarita C., Mazzacca G., Ayala F., Microscopic inflammatory changes in colon of patients with both active psoriasis and psoriatic arthritis without bowel symptoms. Journal of Rheumatology 2000 27 5 1241 1246 2-s2.0-0034023936 (Pubitemid 30262511)
37. Jacques P., Elewaut D., Mielants H., Interactions between gut inflammation and arthritis/spondylitis. Current Opinion in Rheumatology 2010 22 4 368 374 2-s2.0-77953478395 10.1097/BOR.0b013e3283393807
38. Jacques P., Elewaut D., Joint expedition: linking gut inflammation to arthritis. Mucosal Immunology 2008 1 5 364 371 2-s2.0-50149092456 10.1038/mi.2008.24
39. Schlosstein L., Terasaki P. I., Bluestone R., Pearson C. M., High association of an HL-A antigen, W27, with ankylosing spondylitis. The New England Journal of Medicine 1973 288 14 704 706 2-s2.0-0015914854
40. Brown M. A., Pile K. D., Kennedy L. G., Calin A., Darke C., Bell J., Wordsworth B. P., Cornélis F., HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom. Annals of the Rheumatic Diseases 1996 55 4 268 270 2-s2.0-0029879899 (Pubitemid 26120706)
41. Mallas E. G., Mackintosh P., Asquith P., Cooke W. T., Histocompatibility antigens in inflammatory bowel disease; their clinical significance and their association with arthropathy with special reference to HLA B27 (W27). Gut 1976 17 11 906 910 2-s2.0-0017053237 (Pubitemid 8005667)
42. Peeters H., Vander Cruyssen B., Mielants H., de Vlam K., Vermeire S., Louis E., Rutgeerts P., Belaiche J., de Vos M., Clinical and genetic factors associated with sacroiliitis in Crohn's disease. Journal of Gastroenterology and Hepatology 2008 23 1 132 137 2-s2.0-37249021887 10.1111/j.1440-1746.2007.05108. x (Pubitemid 350265198)
43. Orchard T. R., Thiyagaraja S., Welsh K. I., Wordsworth B. P., Gaston J. S. H., Jewell D. P., Clinical phenotype is related to HLA genotype in the peripheral arthropathies of inflammatory bowel disease. Gastroenterology 2000 118 2 274 278 2-s2.0-0033973568 (Pubitemid 30067500)
44. Kuon W., Sieper J., Identification of HLA-B27-restricted peptides in reactive arthritis and other spondyloarthropathies: computer algorithms and fluorescent activated cell sorting analysis as tools for hunting of HLA-B27-restricted chlamydial and autologous crossreactive peptides involved in reactive arthritis and ankylosing spondylitis. Rheumatic Disease Clinics of North America 2003 29 3 595 611 2-s2.0-0042466158 10.1016/S0889-857X(03)00050-4 (Pubitemid 37006323)
45. + T cell response to a single 12-mer epitope of the immunodominant heat-shock protein 60 of Yersinia enterocolitica in Yersinia- triggered reactive arthritis: overlap with the B27-restricted CD8 epitope, functional properties, and epitope presentation by multiple DR alleles. Journal of Immunology 2000 164 3 1529 1537 2-s2.0-0034142024 (Pubitemid 30067270)
46. Thiel A., Wu P., Lauster R., Braun J., Radbruch A., Sieper J., Analysis of the antigen-specific T cell response in reactive arthritis by flow cytometry. Arthritis & Rheumatism 2000 43 12 2834 2842 (Pubitemid 32001751)
47. Scofield R. H., Kurien B., Gross T., Warren W. L., Harley J. B., HLA-B27 binding of peptide from its own sequence and similar peptides from bacteria: implications for spondyloarthropathies. The Lancet 1995 345 8964 1542 1544 2-s2.0-0029046095
48. Ramos M., Alvarez I., Sesma L., Logean A., Rognan D., de López Castro J. A., Molecular mimicry of an HLA-B27-derived ligand of arthritis-linked subtypes with chlamydial proteins. Journal of Biological Chemistry 2002 277 40 37573 37581 2-s2.0-0037020227 10.1074/jbc.M205470200
49. Frauendorf E., von Goessel H., May E., Märker-Hermann E., HLA-B27-restricted T cells from patients with ankylosing spondylitis recognize peptides from B-2705 that are similar to bacteria-derived peptides. Clinical & Experimental Immunology 2003 134 2 351 359 10.1046/j.1365-2249.2003.02289. x (Pubitemid 37372289)
50. Fantini M. C., Pallone F., Monteleone G., Common immunologic mechanisms in inflammatory bowel disease and spondylarthropathies. World Journal of Gastroenterology 2009 15 20 2472 2478 2-s2.0-67650179241 10.3748/wjg.15.2472
51. Baeten D., de Keyser F., Mielants H., Veys E. M., Immune linkages between inflammatory bowel disease and spondyloarthropathies. Current Opinion in Rheumatology 2002 14 4 342 347 2-s2.0-0035985810 10.1097/00002281-200207000- 00002 (Pubitemid 34693975)
52. Uchanska-Ziegler B., Ziegler A., Ankylosing spondylitis: a β 2m-deposition disease? Trends in Immunology 2003 24 2 73 76 2-s2.0-0037289693 10.1016/S1471-4906(02)00028-5 (Pubitemid 36120642)
53. Mielants H., Veys E. M., Goemaere S., Goethals K., Cuvelier C., de Vos M., Gut inflammation in the spondyloarthropathies: clinical, radiologic, biologic and genetic features in relation to the type of histology. A prospective study. Journal of Rheumatology 1991 18 10 1542 1551 2-s2.0-0026327181
54. Hammer R. E., Maika S. D., Richardson J. A., Tang J. P., Taurog J. D., Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human β 2m: an animal model of HLA-B27-associated human disorders. Cell 1990 63 5 1099 1112 2-s2.0-0025633436 10.1016/0092-8674(90)90512-D (Pubitemid 120034950)
55. Taurog J. D., Richardson J. A., Croft J. T., Simmons W. A., Zhou M., Fernández-Sueiro J. L., Balish E., Hammer R. E., The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. Journal of Experimental Medicine 1994 180 6 2359 2364 2-s2.0-0028003794 10.1084/jem.180.6.2359 (Pubitemid 24351619)
56. Hammer M., Zeidler H., Klimsa S., Heesemann J., Yersinia enterocolitica in the synovial membrane of patients with Yersinia-induced arthritis. Arthritis and Rheumatism 1990 33 12 1795 1800 2-s2.0-0025667659 10.1002/art.1780331206
57. Granfors K., Jalkanen S., von Essen R., Lahesmaa-Rantala R., Isomaki O., Pekkola-Heino K., Merilahti-Palo R., Saario R., Isomaki H., Toivanen A., Yersinia antigens in synovial-fluid cells from patients with reactive arthritis. The New England Journal of Medicine 1989 320 4 216 221 2-s2.0-0024593856 (Pubitemid 19034147)
58. Granfors K., Jalkanen S., Toivanen P., Koski J., Lindberg A. A., Bacterial lipopolysaccharide in synovial fluid cells in Shigella triggered reactive arthritis. Journal of Rheumatology 1992 19 3 500 2-s2.0-0026560674
59. Granfors K., Jalkanen S., Lindberg A. A., Maki-Ikola O., von Essen R., Lahesmaa-Rantala R., Isomaki H., Saario R., Arnold W. J., Toivanen A., Salmonella lipopolysaccharide in synovial cells from patients with reactive arthritis. The Lancet 1990 335 8691 685 688 2-s2.0-0025318024 10.1016/0140-6736(90)90804-E (Pubitemid 20089308)
60. Kirveskari J., Jalkanen S., Mäki-Ikola O., Granfors K., Increased synovial endothelium binding and transendothelial migration of mononuclear cells during Salmonella infection. Arthritis & Rheumatism 1998 41 6 1054 1063 (Pubitemid 28265408)
61. Wuorela M., Tohka S., Granfors K., Jalkanen S., Monocytes that have ingested Yersinia enterocolitica serotype O:3 acquire enhanced capacity to bind to nonstimulated vascular endothelial cells via P-selectin. Infection and Immunity 1999 67 2 726 732 2-s2.0-0032956140 (Pubitemid 29059211)
62. Wuorela M., Jalkanen S., Kirveskari J., Laitio P., Granfors K., Yersinia enterocolitica serotype O:3 alters the expression of serologic HLA-B27 epitopes on human monocytes. Infection and Immunity 1997 65 6 2060 2066 2-s2.0-0030914431 (Pubitemid 27237278)
63. Ebringer A., Rashid T., Tiwana H., Wilson C., A possible link between Crohn's disease and ankylosing spondylitis via Klebsiella infections. Clinical Rheumatology 2007 26 3 289 297 2-s2.0-33947677664 10.1007/s10067-006-0391-2 (Pubitemid 46486955)
64. Duerr R. H., Taylor K. D., Brant S. R., Rioux J. D., Silverberg M. S., Daly M. J., Steinhart A. H., Abraham C., Regueiro M., Griffiths A., Dassopoulos T., Bitton A., Yang H., Targan S., Datta L. W., Kistner E. O., Schumm L. P., Lee A. T., Gregersen P. K., Barmada M. M., Rotter J. I., Nicolae D. L., Cho J. H., A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006 314 5804 1461 1463 2-s2.0-33845340501 10.1126/science.1135245 (Pubitemid 44871953)
65. van Praet L., van den Bosch F., Mielants H., Elewaut D., Mucosal inflammation in spondylarthritides: past, present, and future. Current Rheumatology Reports 2011 13 5 409 415 10.1007/s11926-011-0198-2
66. Laukens D., Peeters H., Marichal D., Vander Cruyssen B., Mielants H., Elewaut D., Demetter P., Cuvelier C., van den Berghe M., Rottiers P., Veys E. M., Remaut E., Steidler L., de Keyser F., de Vos M., CARD15 gene polymorphisms in patients with spondyloarthropathies identify a specific phenotype previously related to Crohn's disease. Annals of the Rheumatic Diseases 2005 64 6 930 935 2-s2.0-21144450476 10.1136/ard.2004.028837 (Pubitemid 40733921)
67. Miceli-Richard C., Zouali H., Lesage S., Thomas G., Hugot J. P., Said-Nahal R., Breban M., CARD15/NOD2 analyses in spondylarthropathy. Arthritis and Rheumatism 2002 46 5 1405 1406 2-s2.0-0036095952 10.1002/art.10196 (Pubitemid 34525851)
68. de Vos M., Hindryckx P., Laukens D., Novel development in extraintestinal manifestations and spondylarthropathy. Best Practice and Research: Clinical Gastroenterology 2011 25 1 S19 S26 2-s2.0-79958046377 10.1016/S1521-6918(11) 70006-3
69. van Praet L., Jacques P., van den Bosch F., Elewaut D., The transition of acute to chronic bowel inflammation in spondyloarthritis. Nature Reviews Rheumatology 2012 8 5 288 295 10.1038/nrrheum.2012.42
70. Holden W., Orchard T., Wordsworth P., Enteropathic arthritis. Rheumatic Disease Clinics of North America 2003 29 3 513 530 2-s2.0-0042522555 10.1016/S0889-857X(03)00043-7 (Pubitemid 36993539)
71. Gravallese E. M., Kantrowitz F. G., Arthritic manifestations of inflammatory bowel disease. American Journal of Gastroenterology 1988 83 7 703 709 2-s2.0-0023679830
72. Smale S., Natt R. S., Orchard T. R., Russell A. S., Bjarnason I., Inflammatory bowel disease and spondylarthropathy. Arthritis & Rheumatism 2001 44 12 2728 2736 (Pubitemid 34016191)
73. Rothfuss K. S., Stange E. F., Herrlinger K. R., Extraintestinal manifestations and complications in inflammatory bowel diseases. World Journal of Gastroenterology 2006 12 30 4819 4831 2-s2.0-33748319730 (Pubitemid 44323206)
74. Calin A., Robertson D., Spondylodiscitis and pseudarthrosis in a patient with enteropathic spondyloarthropathy. Annals of the Rheumatic Diseases 1991 50 2 117 119 2-s2.0-0026022492
75. Andersson O., Röntgenbilden vid spondylarthritis ankylopoetica. Nordisk Medicinsk Tidskrift 1937 14 2000 2002
76. Zöld E., Barta Z., Zeher M., Spondylodiscitis representing as the very first sign of Crohn's disease. Inflammatory Bowel Diseases 2007 13 8 1058 2-s2.0-34548191763 10.1002/ibd.20132 (Pubitemid 47309981)
77. Lambert R. G. W., Pedersen S. J., Maksymowych W. P., Chiowchanwisawakit P., Østergaard M., Active inflammatory lesions detected by magnetic resonance imaging in the spine of patients with spondyloarthritis-definitions, assessment system, and reference image set. Journal of Rheumatology 2009 36 supplement 84 3 17 2-s2.0-72749092395 10.3899/jrheum.090616
78. Østergaard M., Maksymowych W. P., Pedersen S. J., Chiowchanwisawakit P., Lambert R. G. W., Structural lesions detected by magnetic resonance imaging in the spine of patients with spondyloarthritis-definitions, assessment system, and reference image set. Journal of Rheumatology 2009 36 supplement 84 18 34 2-s2.0-72749104611 10.3899/jrheum.090617
79. Soscia E., Scarpa R., Cimmino M. A., Atteno M., Peluso R., Sirignano C., Costa L., Iervolino S., Caso F., Del Puente A., Salvatore M., Soricelli A., Magnetic resonance imaging of nail unit in psoriatic arthritis. Journal of Rheumatology. Supplement 2009 36 83 42 45 2-s2.0-70349904456 10.3899/jrheum.090222
80. Kabasakal Y., Garrett S. L., Calin A., The epidemiology of spondylodiscitis in ankylosing spondylitis. A controlled study. British Journal of Rheumatology 1996 35 7 660 663 2-s2.0-0029885321
81. Scarpa R., Discovertebral erosions and destruction in psoriatic arthritis. Journal of Rheumatology 2000 27 4 975 978 2-s2.0-0034044458 (Pubitemid 30389756)
82. Peluso R., Di Minno M. N., Bruner V., Soscia E., Castiglione F., Manguso F., Iervolino S., Scarpa R., Discovertebral erosions in patients with enteropathic spondyloarthritis. The Journal of Rheumatology 2012 39 12 2332 2340 10.3899/jrheum.120415
83. Toussirot E., Wendling D., Crohn's disease associated with seropositive rheumatoid arthritis. Clinical and Experimental Rheumatology 1997 15 3 307 311 2-s2.0-0030938193 (Pubitemid 27261952)
84. Rhew E. Y., Ramsey-Goldman R., Buchman A. L., Sjogren's syndrome in association with Crohn's disease. Journal of Clinical Gastroenterology 2003 37 4 312 314 2-s2.0-0141608921 10.1097/00004836-200310000-00010 (Pubitemid 37168042)
85. Aoyagi S., Akashi H., Kawara T., Ishihara K., Tanaka A., Kanaya S., Koga Y., Ishikawa R., Aortic root replacement for Takayasu arteritis associated with ulcerative colitis and ankylosing spondylitis: report of a case. Japanese Circulation Journal 1998 62 1 64 68 2-s2.0-0031943706 10.1253/jcj.62.64 (Pubitemid 28071142)
86. Hilário M. O. E., Terreri M. T. R. A., Prismich G., Len C., Kihara E. N., Goldenberg J., Solé D., Association of anky-losing spondylitis, Crohn's disease and Takayasu's arteritis in a child. Clinical and Experimental Rheumatology 1998 16 1 92 94 2-s2.0-0031594203 (Pubitemid 28133493)
87. Palm O., Moum B., Jahnsen J., Gran J. T., Fibromyalgia and chronic widespread pain in patients with inflammatory bowel disease: a cross sectional population survey. Journal of Rheumatology 2001 28 3 590 594 2-s2.0-0035094076 (Pubitemid 32202665)
88. Bernstein C. N., Blanchard J. F., Rawsthorne P., Yu N., The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. American Journal of Gastroenterology 2001 96 4 1116 1122 2-s2.0-0035044890 10.1016/S0002-9270(01)02319-X (Pubitemid 32319146)
89. Yüksel I., Başar O., Ataseven H., Ertuǧrul I., Arhan M., Ibiş M., Daǧli U., Demirel B. T., Ulker A., Seçilmiş S., Saşmaz N., Mucocutaneous manifestations in inflammatory bowel disease. Inflammatory Bowel Diseases 2009 15 4 546 550 10.1002/ibd.20807
90. Peluso R., Lupoli G. A., Del Puente A., Iervolino S., Bruner V., Lupoli R., Di Minno M. N., Foglia F., Scarpa R., Lupoli G., Prevalence of thyroid autoimmunity in patients with spondyloarthropathies. Journal of Rheumatology 2011 38 7 1371 1377 2-s2.0-79959981387 10.3899/jrheum.101012
91. Triantafillidis J. K., Manoussakis C. A., Tsafaras C., Koutsorizof A., Coexistence of thyreotoxicosis and exacerbation of ulcerative colitis. American Journal of Gastroenterology 1990 85 7 908 910 2-s2.0-0025146167 (Pubitemid 20280970)
92. Järnerot G., Azad Khan A. K., Truelove S. C., The thyroid in ulcerative colitis and Crohn's disease. II. Thyroid enlargement and hyperthyroidism in ulcerative colitis. Acta Medica Scandinavica 1975 197 1-2 83 87 2-s2.0-0016592832
93. Ha C., Magowan S., Accortt N. A., Chen J., Stone C. D., Risk of arterial thrombotic events in inflammatory bowel disease. American Journal of Gastroenterology 2009 104 6 1445 1451 2-s2.0-66949138571 10.1038/ajg.2009.81
94. Yarur A. J., Deshpande A. R., Pechman D. M., Tamariz L., Abreu M. T., Sussman D. A., Inflammatory bowel disease is associated with an increased incidence of cardiovascular events. The American Journal of Gastroenterology 2011 106 4 741 747 10.1038/ajg.2011.63
95. Papa A., Santoliquido A., Danese S., Covino M., Di Campli C., Urgesi R., Grillo A., Guglielmo S., Tondi P., Guidi L., de Vitis I., Fedeli G., Gasbarrini G., Gasbarrini A., Increased carotid intima-media thickness in patients with inflammatory bowel disease. Alimentary Pharmacology and Therapeutics 2005 22 9 839 846 2-s2.0-27644460489 10.1111/j.1365-2036.2005.02657.x (Pubitemid 41564364)
96. Efremidis M., Prappa E., Kardaras F., Acute myocardial infarction in a young patient during an exacerbation of ulcerative colitis. International Journal of Cardiology 1999 70 2 211 212 2-s2.0-0033620902 10.1016/S0167-5273(99) 00084-4 (Pubitemid 29354375)
97. Mutlu B., Ermeydan C. M. H., Enç F., Fotbolcu H., Demirkol O., Bayrak F., Basaran Y., Acute myocardial infarction in a young woman with severe ulcerative colitis. International Journal of Cardiology 2002 83 2 183 185 2-s2.0-0036247972 10.1016/S0167-5273(02)00043-8 (Pubitemid 34451087)
98. Calderón R., Cruz-Correa M. R., Torres E. A., Cerebral thrombosis associated with active Crohn's disease. Puerto Rico Health Sciences Journal 1998 17 3 293 295 2-s2.0-0032152913
99. Cognat E., Crassard I., Denier C., Vahedi K., Bousser M. G., Cerebral venous thrombosis in inflammatory bowel diseases: eight cases and literature review. International Journal of Stroke 2011 6 6 487 492 10.1111/j.1747-4949. 2011.00620.x
100. Aloi M., Tromba L., Di Nardo G., Dilillo A., Del Giudice E., Marocchi E., Viola F., Civitelli F., Berni A., Cucchiara S., Premature subclinical atherosclerosis in pediatric inflammatory bowel disease. The Journal of Pediatrics 2012 161 4 589 594 10.1016/j.jpeds.2012.03.043
101. Yorulmaz E., Adali G., Yorulmaz H., Ulasoglu C., Tasan G., Tuncer I., Metabolic syndrome frequency in inflammatory bowel diseases. Saudi Journal of Gastroenterology 2011 17 6 376 382 10.4103/1319-3767.87177
102. Oussalah A., Guéant J. L., Peyrin-Biroulet L., Meta-analysis: hyperhomocysteinaemia in inflammatory bowel diseases. Alimentary Pharmacology & Therapeutics 2011 34 10 1173 1184 10.1111/j.1365-2036.2011.04864.x
103. Canero A., Parmeggiani D., Avenia N., Atelli P. F., Goffredi L., Peltrini R., Madonna I., Ambrosino P., Apperti S., Apperti M., Thromboembolic tendency (TE) in IBD, (Inflammatory bowel disease) patients. Annali Italiani di Chirurgia 2012 83 4 313 317
104. Roblin X., Germain E., Phelip J. M., Ducros V., Pofelski J., Heluwaert F., Oltean P., Faucheron J. L., Bonaz B., Factors associated with hyperhomocysteinemia in inflammatory bowel disease: prospective study in 81 patients. Revue de Medecine Interne 2006 27 2 106 110 2-s2.0-31944438322 10.1016/j.revmed.2005.11.005 (Pubitemid 43188740)
105. McGowan C. E., Jones P., Long M. D., Barritt A. S. IV, Changing shape of disease: nonalcoholic fatty liver disease in Crohn's disease-a case series and review of the literature. Inflammatory Bowel Diseases 2012 18 1 49 54 10.1002/ibd.21669
106. Di Minno M. N., Tufano A., Rusolillo A., Di Minno G., Tarantino G., High prevalence of nonalcoholic fatty liver in patients with idiopathic venous thromboembolism. World Journal of Gastroenterology 2010 16 48 6119 6122 2-s2.0-78650765441 10.3748/wjg.v16.i48.6119
107. Di Minno M. N., Iervolino S., Peluso R., Russolillo A., Lupoli R., Scarpa R., Di Minno G., Tarantino G., CaRRDS Study Group, Hepatic steatosis and disease activity in subjects with psoriatic arthritis receiving tumor necrosis factor- α blockers. The Journal of Rheumatology 2012 39 5 1042 1046 10.3899/jrheum.111391
108. Haapamäki J., Roine R. P., Turunen U., Färkkilä M. A., Arkkila P. E. T., Increased risk for coronary heart disease, asthma, and connective tissue diseases in inflammatory bowel disease. Journal of Crohn's and Colitis 2011 5 1 41 47 2-s2.0-78951494562 10.1016/j.crohns.2010.09.008
109. Sridhar A. R. M., Parasa S., Navaneethan U., Crowell M. D., Olden K., Comprehensive study of cardiovascular morbidity in hospitalized inflammatory bowel disease patients. Journal of Crohn's and Colitis 2011 5 4 287 294 2-s2.0-79958803625 10.1016/j.crohns.2011.01.011
110. Osterman M. T., Yang Y. X., Brensinger C., Forde K. A., Lichtenstein G. R., Lewis J. D., No increased risk of myocardial infarction among patients with ulcerative colitis or Crohn's disease. Clinical Gastroenterology and Hepatology 2011 9 10 875 880
111. Dorn S. D., Sandler R. S., Inflammatory bowel disease is not a risk factor for cardiovascular disease mortality: results from a systematic review and meta-analysis. American Journal of Gastroenterology 2007 102 3 662 667 2-s2.0-33847253913 10.1111/j.1572-0241.2006.01018.x (Pubitemid 46328138)
112. Di Minno M. N., Iervolino S., Peluso R., Scarpa R., Di Minno G., TNF- α blockers and carotid intima-media thickness: an emerging issue in the treatment of psoriatic arthritis. Internal and Emergency Medicine 2012 7 supplement 2 97 98
113. Di Minno M. N., Iervolino S., Peluso R., Scarpa R., Di Minno G., Carotid intima-media thickness in psoriatic arthritis: differences between tumor necrosis factor- α blockers and traditional disease-modifying antirheumatic drugs. Arteriosclerosis, Thrombosis, and Vascular Biology 2011 31 3 705 712 2-s2.0-79952189276 10.1161/ATVBAHA.110.214585
114. Bisoendial R. J., Stroes E. S. G., Tak P. P., Where the immune response meets the vessel wall. Netherlands Journal of Medicine 2009 67 8 328 333 2-s2.0-70349656440
115. Di Minno M. N., Iervolino S., Lupoli R., Russolillo A., Coppola A., Peluso R., Scarpa R., Di Minno G., Cardiovascular risk in rheumatic patients: the link between inflammation and atherothrombosis. Seminars in Thrombosis and Hemostasis 2012 38 5 497 505 10.1055/s-0032-1306433
116. Gonzalez-Juanatey C., Llorca J., Amigo-Diaz E., Dierssen T., Martin J., Gonzalez-Gay M. A., High prevalence of subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. Arthritis Care and Research 2007 57 6 1074 1080 2-s2.0-34547781636 10.1002/art.22884 (Pubitemid 47237336)
117. Sari I., Okan T., Akar S., Cece H., Altay C., Secil M., Birlik M., Onen F., Akkoc N., Impaired endothelial function in patients with ankylosing spondylitis. Rheumatology 2006 45 3 283 286 2-s2.0-33644856098 10.1093/rheumatology/kei145 (Pubitemid 43372841)
118. Mathieu S., Joly H., Baron G., Tournadre A., Dubost J. J., Ristori J. M., Lusson J. R., Soubrier M., Trend towards increased arterial stiffness or intima-media thickness in ankylosing spondylitis patients without clinically evident cardiovascular disease. Rheumatology 2008 47 8 1203 1207 2-s2.0-47849108803 10.1093/rheumatology/ken198 (Pubitemid 352038227)
119. Caliskan M., Erdogan D., Gullu H., Yilmaz S., Gursoy Y., Yildirir A., Yucel E., Muderrisoglu H., Impaired coronary microvascular and left ventricular diastolic functions in patients with ankylosing spondylitis. Atherosclerosis 2008 196 1 306 312 2-s2.0-38049082059 10.1016/j.atherosclerosis.2006.11.003
120. Malesci D., Niglio A., Mennillo G. A., Buono R., Valentini G., La Montagna G., High prevalence of metabolic syndrome in patients with ankylosing spondylitis. Clinical Rheumatology 2007 26 5 710 714 2-s2.0-34147169522 10.1007/s10067-006-0380-5 (Pubitemid 46554077)
121. Choe J. Y., Lee M. Y., Rheem I., Rhee M. Y., Park S. H., Kim S. K., No differences of carotid intima-media thickness between young patients with ankylosing spondylitis and healthy controls. Joint Bone Spine 2008 75 5 548 553 2-s2.0-53349092021 10.1016/j.jbspin.2007.11.007
122. Di Minno M. N., Tufano A., Ageno W., Prandoni P., Di Minno G., Identifying high-risk individuals for cardiovascular disease: similarities between venous and arterial thrombosis in perspective. A 2011 update. Internal and Emergency Medicine 2012 7 1 9 13 2-s2.0-79953230131 10.1007/s11739-011-0582- y
123. Ferrer I., Benavent G., Bastida G., Arnau M. A., Iborra M., Beltrán B., Aguas M., Hinojosa J., Nos P., Peripheral arterial thromboembolism in Crohn's disease. Gastroenterología y Hepatología 2013 36 1 30 34 10.1016/j.gastrohep.2012.04.011
124. Tabibian J. H., Streiff M. B., Inflammatory bowel disease-associated thromboembolism: a systematic review of outcomes with anticoagulation versus catheter-directed thrombolysis. Inflammatory Bowel Diseases 2012 18 1 161 171 10.1002/ibd.21307
125. Issa H., Al-Momen S., Bseiso B., Al-Janobi G. A., Aljama M. A., Almousa F. A., Al-Jarodi M. E., Al-Salem A. H., Thomboembolism in inflammatory bowel diseases: a report from Saudi Arabia. Clinical and Experimental Gastroenterology 2011 4 1 1 7 2-s2.0-79952923442 10.2147/CEG.S14918
126. Danese S., Papa A., Saibeni S., Repici A., Malesci A., Vecchi M., Inflammation and coagulation in inflammatory bowel disease: the clot thickens-CME. American Journal of Gastroenterology 2007 102 1 174 186 2-s2.0-33846036404 10.1111/j.1572-0241.2006.00943.x (Pubitemid 46072059)
127. Kume K., Yamasaki M., Tashiro M., Yoshikawa I., Otsuki M., Activations of coagulation and fibrinolysis secondary to bowel inflammation in patients with ulcerative colitis. Internal Medicine 2007 46 17 1323 1330 2-s2.0-34548802477 10.2169/internalmedicine.46.0237 (Pubitemid 47455753)
128. Chiarantini E., Valanzano R., Liotta A. A., Cellai A. P., Fedi S., Ilari I., Prisco D., Tonelli F., Abbate R., Hemostatic abnormalities in inflammatory bowel disease. Thrombosis Research 1996 82 2 137 146 2-s2.0-0029974758 10.1016/0049-3848(96)00060-6 (Pubitemid 26164662)
129. Weber P., Husemann S., Vielhaber H., Zimmer K. P., Nowak-Göttl U., Coagulation and fibrinolysis in children, adolescents, and young adults with inflammatory bowel disease. Journal of Pediatric Gastroenterology and Nutrition
130. van Bodegraven A. A., Schoorl M., Linskens R. K., Bartels P. C., Tuynman H. A., Persistent activation of coagulation and fibrinolysis after treatment of active ulcerative colitis. European Journal of Gastroenterology and Hepatology 2002 14 4 413 418 2-s2.0-0036231237 10.1097/00042737-200204000-00014 (Pubitemid 34439042)
131. Ghosh S., Mackie M. J., McVerry B. A., Galloway M., Ellis A., McKay J., Chronic inflammatory bowel disease, deep-venous thrombosis and antithrombin activity. Acta Haematologica 1983 70 1 50 53 2-s2.0-0020546045 (Pubitemid 13054382)
132. Papa A., Scaldaferri F., Danese S., Guglielmo S., Roberto I., Bonizzi M., Mocci G., Felice C., Ricci C., Andrisani G., Fedeli G., Gasbarrini G., Gasbarrini A., Vascular involvement in inflammatory bowel disease: pathogenesis and clinical aspects. Digestive Diseases 2008 26 2 149 155 2-s2.0-42449091641 10.1159/000116773 (Pubitemid 351572140)
133. Horowitz S., Binion D. G., Nelson V. M., Kanaa Y., Javadi P., Lazarova Z., Andrekopoulos C., Kalyanaraman B., Otterson M. F., Rafiee P., Increased arginase activity and endothelial dysfunction in human inflammatory bowel disease. American Journal of Physiology 2007 292 5 G1323 G1336 2-s2.0-34347379767 10.1152/ajpgi.00499.2006 (Pubitemid 47084650)
134. Morowitz D. A., Allen L. W., Kirsner J. B., Thrombocytosis in chronic inflammatory bowel disease. Annals of Internal Medicine 1968 68 5 1013 1021 2-s2.0-0014285265
135. Yüksel O., Helvaci K., Başar O., Köklü S., Caner S., Helvaci N., Abayli E., Altiparmak E., An overlooked indicator of disease activity in ulcerative colitis: mean platelet volume. Platelets 2009 20 4 277 281 10.1080/09537100902856781
136. Collins C. E., Cahill M. R., Newland A. C., Rampton D. S., Platelets circulate in an activated state in inflammatory bowel disease. Gastroenterology 1994 106 4 840 845 2-s2.0-0028271598 (Pubitemid 24109268)
137. Irving P. M., Macey M. G., Shah U., Webb L., Langmead L., Rampton D. S., Formation of platelet-leukocyte aggregates in inflammatory bowel disease. Inflammatory Bowel Diseases 2004 10 4 361 372 2-s2.0-3543127813 10.1097/00054725-200407000-00007 (Pubitemid 39029179)
138. Bernstein C. N., Wajda A., Blanchard J. F., The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study. Gastroenterology 2005 129 3 827 836 2-s2.0-24144497765 10.1053/j.gastro.2005.06.021 (Pubitemid 41242675)
139. Kaufmann H. J., Taubin H. L., Nonsteroidal anti-inflammatory drugs activate quiescent inflammatory bowel disease. Annals of Internal Medicine 1987 107 4 513 516 2-s2.0-0023266579 (Pubitemid 17149770)
140. Bjarnason I., Hayllar J., MacPherson A. J., Russell A. S., Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology 1993 104 6 1832 1847 2-s2.0-0027244454 (Pubitemid 23235480)
141. Kaufman H. L., Fischer A. H., Carroll M., Becker J. M., Colonic ulceration associated with nonsteroidal anti-inflammatory drugs: report of three cases. Diseases of the Colon and Rectum 1996 39 6 705 710 2-s2.0-0029977243 10.1007/BF02056956 (Pubitemid 26181144)
142. Dissanayake A. S., Truelove S. C., A controlled therapeutic trial of long term maintenance treatment of ulcerative colitis with sulphasalazine (Salazopyrin). Gut 1973 14 12 923 926 2-s2.0-0015724539
143. Dick A. P., Grayson M. J., Carpenter R. G., Petrie A., Controlled trial of sulphasalazine in the treatment of ulcerative colitis. Gut 1964 5 437 442 10.1136/gut.5.5.437
144. Ferraz M. B., Tugwell P., Goldsmith C. H., Atra E., Meta-analysis of sulfasalazine in ankylosing spondylitis. Journal of Rheumatology 1990 17 11 1482 1486 2-s2.0-0025201104
145. Rodríguez-Bores L., Barahona-Garrido J., Yamamoto-Furusho J. K., Basic and clinical aspects of osteoporosis in inflammatory bowel disease. World Journal of Gastroenterology 2007 13 46 6156 6165 2-s2.0-37848998588 10.3748/wjg.13.6156
146. Padovan M., Castellino G., Govoni M., Trotta F., The treatment of the rheumatologicalmanifestations of the inflammatoryboweldiseases. Rheumatology International 2006 26 11 953 958 10.1007/s00296-006-0148-x (Pubitemid 44403600)
147. de Keyser F., van Damme N., de Vos M., Mielants H., Veys E. M., Opportunities for immune modulation in the spondyloarthropathies with special reference to gut inflammation. Inflammation Research 2000 49 2 47 54 2-s2.0-0033995141 10.1007/s000110050558 (Pubitemid 30123844)
148. Chen J., Liu C., Methotrexate for ankylosing spondylitis. Cochrane Database of Systematic Reviews 2004 3 CD004524 2-s2.0-16544373476
149. Haibel H., Rudwaleit M., Braun J., Sieper J., Six months open label trial of leflunomide in active ankylosing spondylitis. Annals of the Rheumatic Diseases 2005 64 1 124 126 2-s2.0-11344271068 10.1136/ard.2003.019174 (Pubitemid 40075288)
150. Peluso R., Atteno M., Iervolino S., Bruner V., Caso F., Costa L., Raimondo M., Lofrano M., Manguso F., Scarpa R., Methotrexate in the treatment of peripheral arthritis in ulcerative colitis. Reumatismo 2009 61 1 15 20 2-s2.0-66149116476
151. van den Bosch F., Kruithof E., de Vos M., de Keyser F., Mielants H., Crohn's disease associated with spondyloarthropathy: effect of TNF- α blockade with infliximab on articular symptoms. The Lancet 2000 356 9244 1821 1822 2-s2.0-0034715977
152. Marzo-Ortega H., McGonagle D., O'Connor P., Emery P., Efficacy of etanercept for treatment of Crohn's related spondyloarthritis but not colitis. Annals of the Rheumatic Diseases 2003 62 1 74 76 2-s2.0-0037214122 10.1136/ard.62.1.74 (Pubitemid 36005801)
153. Iervolino S., Tramontano G., Lofrano M., Peluso R., Atteno M., Bruner V., Di Minno M. N., Costa L., Scarpa R., Etanercept nel trattamento dell'artrite enteropatica associata a malattia di Crohn: descrizione di un caso clinico. Reumatismo 2011 63 supplement 3 125
154. Neuman M. G., Nanau R. M., Inflammatory bowel disease: role of diet, microbiota, life style. Translational Research 2012 160 1 29 44
155. Veerappan G. R., Betteridge J., Young P. E., Probiotics for the treatment of inflammatory bowel disease. Current Gastroenterology Reports 2012 14 4 324 333 10.1007/s11894-012-0265-5
156. Karimi O., Peña A. S., Probiotics in arthralgia and spondyloarthropathies in patients with inflammatory bowel disease. Prospective randomized trials are necessary. Revista Espanola de Enfermedades Digestivas 2005 97 8 570 574 2-s2.0-33644873829 (Pubitemid 43797763)
157. Rudwaleit M., Baeten D., Ankylosing spondylitis and bowel disease. Best Practice and Research: Clinical Rheumatology 2006 20 3 451 471 2-s2.0-33744931901 10.1016/j.berh.2006.03.010 (Pubitemid 43843072)
158. Behm B. W., Bickston S. J., Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease. Cochrane Database of Systematic Reviews 2008 1 CD006893 2-s2.0-41949106991
159. Gandhi S., Narula N., Marshall J. K., Farkouh M., Are patients with inflammatory bowel disease at increased risk of coronary artery disease? The American Journal of Medicine 2012 125 10 956 962 10.1016/j.amjmed.2012.03.015